Interactions between Xenobiotics and DME (XEOTIC)
|
Fungicide(s), Herbicide(s) or Insecticide(s) |
Fungicide |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
2,4,6-trichlorophenol |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00962
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Fungicide |
DME Modulation |
2,4,6-trichlorophenol inhibits the expression of DME CYP11A1 |
[1] |
Hexachlorobenzene |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00951
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Fungicide |
DME Modulation |
Hexachlorobenzene induces the drug-metabolizing activity of DME CYP11A1 |
[2] |
Herbicide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Atrazine |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00969
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Herbicide |
DME Modulation |
Atrazine up-regulates the expression of DME CYP11A1 |
[3] |
Health or Environmental Toxicant(s) |
Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Formaldehyde |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01305
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Formaldehyde inhibits the expression of DME CYP11A1 |
[4] |
Pentabromophenol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00904
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Pentabromophenol up-regulates the expression of DME CYP11A1 |
[5] |
Environmental Pollutant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
2-bromophenol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01121
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Environmental Pollutant |
DME Modulation |
2-bromophenol up-regulates the expression of DME CYP11A1 |
[6] |
Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Dibutyl phthalate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01275
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Health and Environmental Toxicant |
DME Modulation |
Dibutyl phthalate inhibits the expression of DME CYP11A1 |
[7] |
Diethylhexyl phthalate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01004
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Health Hazard |
DME Modulation |
Diethylhexyl phthalate up-regulates the expression of DME CYP11A1 |
[8] |
Tris(1,3-dichloro-2-propyl)phosphate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01031
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Health Hazard |
DME Modulation |
Tris(1,3-dichloro-2-propyl)phosphate up-regulates the expression of DME CYP11A1 |
[9] |
Natural Product(s), Extract(s) or Medicine(s) |
Natural Mixture |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Water pollutants chemical |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00924
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Natural Mixture |
DME Modulation |
Water pollutants chemical induces the drug-metabolizing activity of DME CYP11A1 |
[10] |
Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Cholesteryl sulfate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00911
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Product |
DME Modulation |
Cholesteryl sulfate inhibits the expression of DME CYP11A1 |
[11] |
Walrycin A |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01498
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Product |
DME Modulation |
Walrycin A up-regulates the expression of DME CYP11A1 |
[12] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 12 Xenobiotics
|
Calcitriol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00184
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Calcitriol up-regulates the expression of DME CYP11A1 |
[13] |
Diethylstilbestrol |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00166
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Diethylstilbestrol inhibits the expression of DME CYP11A1 |
[14] |
Dinoprostone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00260
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Dinoprostone up-regulates the expression of DME CYP11A1 |
[15] |
Estradiol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00090
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Estradiol up-regulates the expression of DME CYP11A1 |
[14] |
Hydrocortisone |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00264
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Hydrocortisone inhibits the drug-metabolizing activity of DME CYP11A1 |
[16] |
Lindane |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00740
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Lindane inhibits the expression of DME CYP11A1 |
[17] |
Mitotane |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00064
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Mitotane inhibits the drug-metabolizing activity of DME CYP11A1 |
[18] |
Nicotine polacrilex |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00312
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Nicotine polacrilex inhibits the expression of DME CYP11A1 |
[19], [20] |
Perflubron |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00104
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Perflubron up-regulates the expression of DME CYP11A1 |
[21] |
Testosterone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00095
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Testosterone up-regulates the expression of DME CYP11A1 |
[22] |
Valproic acid |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00029
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Valproic acid inhibits the drug-metabolizing activity of DME CYP11A1 |
[23] |
Methoxychlor |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00446
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Marketed but not Approved by US FDA |
DME Modulation |
Methoxychlor induces the drug-metabolizing activity of DME CYP11A1 |
[24] |
Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Resveratrol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00568
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Resveratrol up-regulates the expression of DME CYP11A1 |
[25] |
Vanadyl sulfate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00602
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Vanadyl sulfate up-regulates the expression of DME CYP11A1 |
[26], [27] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Bisphenol A |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01226
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Bisphenol A inhibits the drug-metabolizing activity of DME CYP11A1 |
[28], [29] |
Colforsin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00606
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Colforsin up-regulates the expression of DME CYP11A1 |
[30] |
Ethanol |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00539
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Ethanol inhibits the expression of DME CYP11A1 |
[31] |
Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Cyclic AMP |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01267
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Cyclic AMP induces the drug-metabolizing activity of DME CYP11A1 |
[29] |
Dihydrotestosterone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00536
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Dihydrotestosterone up-regulates the expression of DME CYP11A1 |
[32] |
Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Antalarmin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00709
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug in Preclinical Study |
DME Modulation |
Antalarmin inhibits the expression of DME CYP11A1 |
[33] |
GW-3965 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01325
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Patented Pharmaceutical Agent |
DME Modulation |
GW-3965 inhibits the expression of DME CYP11A1 |
[34] |
Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
3,3',4,5'-tetrahydroxystilbene |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01133
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Investigative Agent |
DME Modulation |
3,3',4,5'-tetrahydroxystilbene inhibits the expression of DME CYP11A1 |
[35] |
Astressin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01210
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Investigative Agent |
DME Modulation |
Astressin inhibits the expression of DME CYP11A1 |
[33] |
Go-6976 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01321
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Investigative Agent |
DME Modulation |
Go-6976 up-regulates the expression of DME CYP11A1 |
[36] |
Other Chemical Compound(s) or Element(s) |
Cosmetic Additive |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
2-acetyltributylcitrate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01612
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Cosmetic Additive |
DME Modulation |
2-acetyltributylcitrate up-regulates the expression of DME CYP11A1 |
[30] |
|
|
|
|
|
|